{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:32:26Z","timestamp":1746325946169,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00595-020-02188-z","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T05:02:41Z","timestamp":1609563761000},"page":"978-985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The clinical significance of preoperative C-reactive protein\/albumin ratio in patients with resected extrahepatic bile duct cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Du Hyun","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Kuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Seok","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hyeok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Seong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-1415","authenticated-orcid":false,"given":"Jaihwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"issue":"1","key":"2188_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2188_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11894-017-0542-4","volume":"19","author":"B Doherty","year":"2017","unstructured":"Doherty B, Nambudiri VE, Palmer WC. Update on the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19(1):2.","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"2188_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9935","key":"2188_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"issue":"9","key":"2188_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349\u201369.","journal-title":"Cancer"},{"issue":"6","key":"2188_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cgh.2016.12.038","volume":"15","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Tazuma S, Okazaki K, Nakazawa T, Inui K, Chiba T, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15(6):920\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2188_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jhbp.432","volume":"24","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Tazuma S, Nakazawa T, Isayama H, Tsuyuguchi T, Inui K, et al. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan. J Hepato Biliary Pancreat Sci. 2017;24(4):217\u201325.","journal-title":"J Hepato Biliary Pancreat Sci"},{"issue":"2","key":"2188_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/bjc.2017.401","volume":"118","author":"Y Kitano","year":"2018","unstructured":"Kitano Y, Okabe H, Yamashita YI, Nakagawa S, Saito Y, Umezaki N, et al. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma. Br J Cancer. 2018;118(2):171\u201380. https:\/\/doi.org\/10.1038\/bjc.2017.401.","journal-title":"Br J Cancer"},{"issue":"8","key":"2188_CR9","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1007\/s00268-012-1594-0","volume":"36","author":"JY Cho","year":"2012","unstructured":"Cho JY, Han HS, Yoon YS, Hwang DW, Jung K, Kim JH, et al. Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer. World J Surg. 2012;36(8):1842\u20137. https:\/\/doi.org\/10.1007\/s00268-012-1594-0.","journal-title":"World J Surg"},{"issue":"2","key":"2188_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/bjc.2013.332","volume":"109","author":"M Stotz","year":"2013","unstructured":"Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416\u201321. https:\/\/doi.org\/10.1038\/bjc.2013.332.","journal-title":"Br J Cancer"},{"issue":"4","key":"2188_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjsurg.2007.12.057","volume":"197","author":"RA Smith","year":"2009","unstructured":"Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197(4):466\u201372. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.12.057.","journal-title":"Am J Surg"},{"issue":"5","key":"2188_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00595-009-4065-y","volume":"40","author":"T Nozoe","year":"2010","unstructured":"Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40(5):440\u20133. https:\/\/doi.org\/10.1007\/s00595-009-4065-y.","journal-title":"Surg Today"},{"issue":"8","key":"2188_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1478-3231.2007.01550.x","volume":"27","author":"S Nagaoka","year":"2007","unstructured":"Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, et al. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int. 2007;27(8):1091\u20137. https:\/\/doi.org\/10.1111\/j.1478-3231.2007.01550.x.","journal-title":"Liver Int"},{"issue":"34","key":"2188_CR14","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.3748\/wjg.v12.i34.5495","volume":"12","author":"T Gerhardt","year":"2006","unstructured":"Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, et al. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol. 2006;12(34):5495\u2013500. https:\/\/doi.org\/10.3748\/wjg.v12.i34.5495.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"2188_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1097\/PAS.0000000000000957","volume":"41","author":"Y-C Yeh","year":"2017","unstructured":"Yeh Y-C, Lei H-J, Chen M-H, Ho H-L, Chiu L-Y, Li C-P, et al. C-reactive protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis. Am J Surg Pathol. 2017;41(12):1630\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2188_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s12885-016-2827-7","volume":"16","author":"Z-Y Lin","year":"2016","unstructured":"Lin Z-Y, Liang Z-X, Zhuang P-L, Chen J-W, Cao Y, Yan L-X, et al. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer. 2016;16(1):792.","journal-title":"BMC Cancer"},{"issue":"4","key":"2188_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3747\/co.v17i4.567","volume":"17","author":"G Kasymjanova","year":"2010","unstructured":"Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17(4):52\u20138. https:\/\/doi.org\/10.3747\/co.v17i4.567.","journal-title":"Curr Oncol"},{"issue":"5","key":"2188_CR18","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.21873\/anticanres.13388","volume":"39","author":"Y Nakao","year":"2019","unstructured":"Nakao Y, Yamashita Y-I, Arima K, Miyata T, Itoyama R, Yusa T, et al. Clinical usefulness of perioperative c-reactive protein\/albumin ratio in patients with intrahepatic cholangiocarcinoma: a retrospective single institutional study. Anticancer Res. 2019;39(5):2641\u20136.","journal-title":"Anticancer Res"},{"issue":"1","key":"2188_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","volume":"25","author":"S Kiriyama","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepato Biliary Pancreat Sci. 2018;25(1):17\u201330.","journal-title":"J Hepato Biliary Pancreat Sci"},{"issue":"1","key":"2188_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jhbp.515","volume":"25","author":"M Yokoe","year":"2018","unstructured":"Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepato Biliary Pancreat Sci. 2018;25(1):41\u201354.","journal-title":"J Hepato Biliary Pancreat Sci"},{"key":"2188_CR21","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz A, Greene F. AJCC cancer staging manual. New York: Springer; 2010."},{"issue":"1","key":"2188_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","volume":"241","author":"JY Jang","year":"2005","unstructured":"Jang JY, Kim SW, Park DJ, Ahn YJ, Yoon YS, Choi MG, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg. 2005;241(1):77\u201384. https:\/\/doi.org\/10.1097\/01.sla.0000150166.94732.88.","journal-title":"Ann Surg"},{"issue":"2","key":"2188_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3978\/j.issn.2078-6891.2011.021","volume":"3","author":"UK Ballehaninna","year":"2012","unstructured":"Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3(2):105\u201319. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2011.021.","journal-title":"J Gastrointest Oncol"},{"issue":"20","key":"2188_CR24","first-page":"5501","volume":"47","author":"MA Tempero","year":"1987","unstructured":"Tempero MA, Uchida E, Takasaki H, Burnett DA, Steplewski Z, Pour PM. Relationship of carbohydrate antigen 19-9 and lewis antigens in pancreatic cancer. Cancer Res. 1987;47(20):5501\u20133.","journal-title":"Cancer Res"},{"issue":"3","key":"2188_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1245\/s10434-014-4048-0","volume":"22","author":"A Kinoshita","year":"2015","unstructured":"Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2188_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/bjc.2013.701","volume":"110","author":"J Szkandera","year":"2014","unstructured":"Szkandera J, Stotz M, Absenger G, Stojakovic T, Samonigg H, Kornprat P, et al. Validation of C-reactive protein levels as a prognostic indicator for the survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014;110(1):183\u20138.","journal-title":"Br J Cancer"},{"issue":"6917","key":"2188_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137. https:\/\/doi.org\/10.1038\/nature01322.","journal-title":"Nature"},{"issue":"5","key":"2188_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2354.2012.01363.x","volume":"21","author":"V Prevost","year":"2012","unstructured":"Prevost V, Grach MC. Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care. 2012;21(5):581\u201390.","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"2188_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tranon.2015.06.006","volume":"8","author":"X Liu","year":"2015","unstructured":"Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, et al. Preoperative C-reactive protein\/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339\u201345. https:\/\/doi.org\/10.1016\/j.tranon.2015.06.006.","journal-title":"Transl Oncol"},{"issue":"1","key":"2188_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12885-015-1379-6","volume":"15","author":"X-L Wei","year":"2015","unstructured":"Wei X-L, Wang F-H, Zhang D-S, Qiu M-Z, Ren C, Jin Y, et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein\/albumin ratio. BMC cancer. 2015;15(1):350.","journal-title":"BMC cancer."},{"issue":"1","key":"2188_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/kjm2.12129","volume":"36","author":"Y Wang","year":"2020","unstructured":"Wang Y, Hu X, Huang Y, Xu WY, Wu YM, Li PF, et al. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: a systematic review and meta-analysis. Kaohsiung J Med Sci. 2020;36(1):54\u201361. https:\/\/doi.org\/10.1002\/kjm2.12129.","journal-title":"Kaohsiung J Med Sci"},{"issue":"29","key":"2188_CR32","doi-asserted-by":"publisher","first-page":"e16064","DOI":"10.1097\/MD.0000000000016064","volume":"98","author":"F Wang","year":"2019","unstructured":"Wang F, Li P, Li F-S. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: a meta analysis. Medicine. 2019;98(29):e16064. https:\/\/doi.org\/10.1097\/MD.0000000000016064.","journal-title":"Medicine."},{"issue":"6","key":"2188_CR33","doi-asserted-by":"publisher","first-page":"BSR20180686","DOI":"10.1042\/BSR20180686","volume":"38","author":"N Gao","year":"2018","unstructured":"Gao N, Yang R-N, Meng Z, Wang W-H. The prognostic value of C-reactive protein\/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Biosci Rep. 2018;38(6):BSR20180686. https:\/\/doi.org\/10.1042\/BSR20180686.","journal-title":"Biosci Rep"},{"issue":"1","key":"2188_CR34","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41598-017-03153-6","volume":"7","author":"J Hang","year":"2017","unstructured":"Hang J, Xue P, Yang H, Li S, Chen D, Zhu L, et al. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Sci Rep. 2017;7(1):2993.","journal-title":"Sci Rep"},{"issue":"9","key":"2188_CR35","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00268-016-3491-4","volume":"40","author":"K Haruki","year":"2016","unstructured":"Haruki K, Shiba H, Shirai Y, Horiuchi T, Iwase R, Fujiwara Y, et al. The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection. World J Surg. 2016;40(9):2254\u201360.","journal-title":"World J Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-02188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-020-02188-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-02188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T03:18:10Z","timestamp":1621826290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-020-02188-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1007\/s00595-020-02188-z","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"type":"print","value":"0941-1291"},{"type":"electronic","value":"1436-2813"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}